Wiener klinische Wochenschrift · 2026
Effects of implementing a clinical scoring system on the management of infants with RSV bronchiolitis.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Konzett K, Polzer C, Wippel A, Simma B
Аннотация
INTRODUCTION: Respiratory syncytial virus (RSV) is a common pathogen of lower respiratory tract infections in infants 1 month to 1 year of age. Infections with RSV are the most common cause for hospitalization for respiratory infections and present with a high rate of complications. Different scores for severity assessment currently exist but only few of them are well validated. The "Inpatient clinical pathway for evaluation/treatment of children with bronchiolitis" from the Children's Hospital of Philadelphia (CHOP) provides clear and concise guidance for severity grading and inpatient management.
AIM: In 2019 we implemented a bronchiolitis scoring system and pathway in accordance with the CHOP pathway in our inpatient setting to assess and monitor children affected by bronchiolitis as well as to plan their discharge. This study investigated the length of stay before and after implementation of the score and the risk of readmission after regular discharge.
METHODS: Data from all admitted infants 1 month to 1 year of age with a discharge diagnosis of acute bronchiolitis due to RSV (ICD 10-GM 2024 J21.0, n = 261) over a period of 9 years were evaluated, 5 winters (2014-2019, n = 140) before (group 1) and 4 winters (2020-2024, n = 121) after (group 2) implementation of the score.
RESULTS: The study population did not differ before and after implementation of the score with respect to age (group 1: mean age = 99.9 ± 87.3 days vs. group 2: 120.2 ± 85.6 days) and sex. The groups were equally sized with a mean of 28-30 patients per season. The average length of stay was 5.5 ± 3.4 SD days. Although the length of stay before and after implementation decreased on average by 0.4 days the result was not significant (5.6 ± 3.8 SD vs. 5.3 ± 2.8 SD days, p = 0.2). The readmission rate in total was very low (5/261, 1.7%) and only 1 patient had to be readmitted after implementation of the score (4/140, 2.8% vs. 1/121, 0.8%, p = 0.38).
CONCLUSION: This structured clinical bronchiolitis pathway provides concise advice for outpatient as well as inpatient management. The length of stay did not differ before and after implementation. The score is a safe and useful tool for preventing readmission.
AIM: In 2019 we implemented a bronchiolitis scoring system and pathway in accordance with the CHOP pathway in our inpatient setting to assess and monitor children affected by bronchiolitis as well as to plan their discharge. This study investigated the length of stay before and after implementation of the score and the risk of readmission after regular discharge.
METHODS: Data from all admitted infants 1 month to 1 year of age with a discharge diagnosis of acute bronchiolitis due to RSV (ICD 10-GM 2024 J21.0, n = 261) over a period of 9 years were evaluated, 5 winters (2014-2019, n = 140) before (group 1) and 4 winters (2020-2024, n = 121) after (group 2) implementation of the score.
RESULTS: The study population did not differ before and after implementation of the score with respect to age (group 1: mean age = 99.9 ± 87.3 days vs. group 2: 120.2 ± 85.6 days) and sex. The groups were equally sized with a mean of 28-30 patients per season. The average length of stay was 5.5 ± 3.4 SD days. Although the length of stay before and after implementation decreased on average by 0.4 days the result was not significant (5.6 ± 3.8 SD vs. 5.3 ± 2.8 SD days, p = 0.2). The readmission rate in total was very low (5/261, 1.7%) and only 1 patient had to be readmitted after implementation of the score (4/140, 2.8% vs. 1/121, 0.8%, p = 0.38).
CONCLUSION: This structured clinical bronchiolitis pathway provides concise advice for outpatient as well as inpatient management. The length of stay did not differ before and after implementation. The score is a safe and useful tool for preventing readmission.